home / Switzerland / Banque Cantonale Vaudoise

Banque Cantonale Vaudoise Market Cap

$10.42 B

-0.02 B

SIX:BCVN.SW · April 19, 2025

Share price

$121.26

Enterprise Value

$15.78 B

Change (1-Year)

-1.7%

Global Rank

#1562

Country Rank

#39

Regions

Switzerland

Market cap

As of April 19, 2025, Banque Cantonale Vaudoise (BCVN.SW) has a market cap of $10.42 billion USD. According to our data, Banque Cantonale Vaudoise is ranked No.1562 in global market value.

Sector Rank:

Financial services #251 Banks #158

BCVN.SW Market Capitalization Growth

1 Years Growth:

-1.7%

3 Years Growth:

29.3%

5 Years Growth:

37.6%

10 Years Growth:

138.3%

15 Years Growth:

202.8%

20 Years Growth:

504.3%

Total Growth:

1965%

Banque Cantonale Vaudoise Market Cap Chart

YTD

10Y

15Y

20Y

MAX

Banque Cantonale Vaudoise Market Cap CAGR Chart

Banque Cantonale Vaudoise Market Cap History 2002 - 2025

Year	Market Cap	%Change
Apr 19, 2025	$10.42 B	18.47%
Dec 30, 2024	$8.79 B	-19.58%
Dec 29, 2023	$10.93 B	27.60%
Dec 30, 2022	$8.57 B	31.22%
Dec 30, 2021	$6.53 B	-23.52%
Dec 30, 2020	$8.54 B	27.36%
Dec 30, 2019	$6.70 B	11.55%
Dec 28, 2018	$6.01 B	5.07%
Dec 29, 2017	$5.72 B	15.56%
Dec 30, 2016	$4.95 B	2.83%
Dec 30, 2015	$4.81 B	20.19%
Dec 30, 2014	$4.01 B	12.96%
Dec 30, 2013	$3.55 B	2.20%
Dec 28, 2012	$3.47 B	8.41%
Dec 30, 2011	$3.20 B	-5.32%
Dec 30, 2010	$3.38 B	23.01%
Dec 31, 2009	$2.75 B	36.14%
Dec 31, 2008	$2.02 B	-34.36%
Dec 31, 2007	$3.08 B	-13.68%
Dec 29, 2006	$3.56 B	56.88%
Dec 30, 2005	$2.27 B	86.84%
Dec 31, 2004	$1.22 B	46.79%
Dec 31, 2003	$0.83 B	76.25%
Dec 31, 2002	$0.47 B	100%

Similar Companies to Banque Cantonale Vaudoise

Name	Market Cap	Market cap difference	Regions
BioNTech BNTX	$23.74 B	0.000 M	Germany
Moderna MRNA	$9.56 B	-0.000 M	USA
Regeneron Pharmaceuticals REGN	$61.57 B	1.023 B	USA
Gilead Sciences GILD	$130.32 B	-0.001 M	USA
Pfizer PFE	$125.57 B	0.001 M	USA
Johnson & Johnson JNJ	$379.48 B	-0.003 M	USA
AstraZeneca AZN	$210.29 B	0.735 B	UK
Merck MRK	$196.28 B	0.008 M	USA
Sanofi SNY	$124.64 B	0.327 B	France
Eli Lilly LLY	$754.27 B	0.008 M	USA
Novavax NVAX	$0.97 B	0.000 M	USA
GlaxoSmithKline GSK	$72.79 B	-0.000 M	UK
AbbVie ABBV	$306.02 B	0.008 M	USA
Amgen AMGN	$149.09 B	0.124 B	USA

About Banque Cantonale Vaudoise Inc.

Name

BC VAUD N

Website

https://www.bcv.ch

Headquarters

Lausanne,None

symbol

BCVN.SW

CURRENCY

CHF

country

Switzerland

fullTimeEmployees

2089

exchange

EBS

firstTradeDateEpochUtc

1970/01/01

BCVN.SW Market Cap Formula

Market Cap	=	BCVN.SW Stock Price	*	BCVN.SW Shares Outstanding
	=	$121.26	*	85.91 M
	=	$10.42 B

What is Market Cap?

Market capitalization represents the market's valuation of a company, calculated by multiplying the current share price by the total number of outstanding shares. It helps to assess the company's size and allows for comparison with other companies.

Material

wikipedia Share_price outstanding

What is Market Capitalization?

Market capitalization, or market cap, is a key measure of a company's market value. It is calculated by multiplying the current stock price by the total number of outstanding shares. Market cap is often used by investors to assess a company's size, stability, and market presence. For any inquiries or to report an issue, please email us at [email protected].

Disclaimer

This website provides general information only. While we aim for accuracy, we do not guarantee data completeness or reliability. Consult a financial advisor before investing. We are not responsible for any losses or damages from using this site. By using it, you agree to these terms. Company logos belong to their respective copyright holders and are shown for editorial purposes only. Prices are not in real time.

America

Europe